Fingerprint
Dive into the research topics of 'Dosage adjustment during long-term adalimumab treatment for Crohn's disease: Clinical efficacy and pharmacoeconomics'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
William J. Sandborn, Jean Frédéric Colombel, Stefan Schreiber, Scott E. Plevy, Paul F. Pollack, Anne M. Robinson, Jingdong Chao, Parvez Mulani
Research output: Contribution to journal › Article › peer-review